Tandem Diabetes Care, Inc.

NASDAQ:TNDM

Medical - Devices

Healthcare
$17.05 +1.53%

+$0.24 today

Market cap
$1.19B
Beta
1.57
P/E (TTM)
-11.3
EPS (TTM)
-$1.38
52W Low $9.98High $29.65

Volume 2.35M

Average 2.43M

TNDM Sales of Investments

Cash received from selling or redeeming investments.

Tandem Diabetes Care, Inc.NASDAQ: TNDM

Sales of Investments · Q1 FY2026 · quarter ended Mar 2026

Sales of investments declines year over year

Q1 FY2026 sales of investments of $26.95M fell 58.6% year over year, behind the -43.6% change in trailing-twelve-month sales of investments. Over 3 fiscal years it compounded at -23.3% a year.

Context

  • Sales of investments amounted to 25.3% of revenue in FY2025, down 7.3 pp from a year earlier.
  • Sales of investments increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -58.6% toward the trailing-twelve-month pace of -43.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$26.95M— QoQ
Last fiscal yearDec 2025
$257.07M-16.1% YoY
LTMMar 2026
$162.47M-43.6% YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-58.6%——
1 year-16.1%——
3-year CAGR-23.3%——
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
257.07M USD
Year-over-year change
-16.1%
4-year CAGR
-18.1%

Sales of Investments vs competitors

How TNDM compares with its peers on the latest reported figures

  • TNDM's LTM Mar 2026 sales of investments of $162.47M is the 4th largest of the 8 companies compared; the peer median is $71.65M.
  • Its year-over-year change of -43.6% is the lowest of 5, against a peer median of -2.7%.
  • Sales of investments amounts to 15.8% of revenue for TNDM, versus a peer median of 46.0%.
TNDM Competitors Peer median
Sales of Investments for TNDM and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DXCMDexCom, Inc.LTM Jun 2026$1.87B -19.6%+0.6%37.6%
MNKDMannKind CorporationLTM Mar 2026$195.82M -11.7%—54.3%
BBNXBeta Bionics, Inc.LTM Mar 2026$190M +106.5%—172.4%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$162.47M -43.6%-23.3%15.8%
SENSSenseonics Holdings, Inc.LTM Mar 2026$71.65M +6.3%-28.4%176.0%
PODDInsulet CorporationLTM Jun 2026$0 ——0.0%
MMEDMiniMed Group, Inc. Common StockLTM Jul 2026$0 ——0.0%
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$0 ———
MMEDVMiniMed Group, Inc.—— ———
Peer median (excluding TNDM) $71.65M-2.7%-13.9%46.0%

Competitors are the stored peer set for TNDM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income15.57M(94.59M)(222.61M)(96.03M)(204.71M)
Depreciation & Amortization13.85M14.33M15.72M16.61M13.84M
Deferred Income Tax00000
Stock-Based Compensation60.75M84.92M88.08M101.38M92.38M
Change in Working Capital14.37M(4.65M)(17.69M)(11.78M)(23.04M)
Accounts Receivables(30.98M)(7.83M)4.28M(20.8M)(56.81M)
Inventory(4.95M)(42.45M)(46.05M)5.81M24.82M
Accounts Payables10.28M24.49M(4.86M)(2.39M)2.23M
Other Working Capital40.03M21.14M28.96M5.6M6.73M
Other Non-Cash Items6.82M50.46M104.7M14.04M111.81M
Operating Cash Flow111.36M50.46M(31.81M)24.23M(9.72M)
Capital Expenditures(23.51M)(34.1M)(26.8M)(19.23M)(19.95M)
Acquisitions (Net)0(25.72M)(69.5M)00
Purchases of Investments(733.39M)(467.65M)(535.66M)(264.31M)(85.66M)
Sales of Investments570.02M569.49M546.22M306.46M257.07M
Other Investing Activities(9.33M)(8.86M)0(46.4M)(78.59M)
Investing Cash Flow(186.88M)33.17M(85.74M)(23.48M)72.88M
Debt Repayment00044.91M(40.76M)
Common Stock Issued017.55M0(6.73M)(2.61M)
Common Stock Repurchased000(30M)0
Dividends Paid00000
Other Financing Activities51.93M(675K)4.11M183K0
Financing Cash Flow51.93M16.88M4.11M8.37M(43.37M)
Effect of Forex Changes153K827K(212K)1.26M1.61M
Net Change in Cash(23.43M)101.34M(113.65M)10.37M21.4M
Free Cash Flow87.85M16.37M(58.61M)4.99M(29.67M)

Tandem Diabetes Care, Inc.

NASDAQ:TNDM

Intrinsic Alpha fair value

Locked

Current Price

$17.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.